In the last months, researchers from laboratories around the world had constantly been trying to figure out both treatment and vaccine for the SARS-CoV-2 virus that caused a lot of havoc across the globe. However, there are plenty of countries that were affected very little by COVID-19, like Mongolia, Cambodia, Mauritius, Comoros, Gibraltar, Curacao, and more.
Plenty of scientists had been clinging to a lot of hope that the anti-malarial drug hydroxychloroquine can cure patients affected by the coronavirus, but it seems that the researchers will have to shift their focus elsewhere.
IDSA says no to hydroxychloroquine
The Infectious Diseases Society of America (IDSA) doesn’t recommend hydroxychloroquine as a treatment for the SARS-CoV-2 virus. Initially, the IDSA only recommended against the use of the anti-malarial drug while paired with an antibiotic called azithromycin. They said in a statement the following:
“IDSA’s expert guidelines panel concluded that higher certainty benefits (e.g., mortality reduction) for the use of these treatments are now highly unlikely even if additional high quality data would become available,”
After trials of the drug, it was found that patients suffering from COVID-19 that were treated with hydroxychloroquine ‘were more likely to be placed on a mechanical ventilation during follow up’. However, another major drawback of the drug is that it can cause serious heart problems. Doctors warned about this before, but the drug could have been the only chance that some patients had.
With certain regions of the globe experiencing a second wave of COVID-19, there’s no telling when this nightmare will finally end. Countries like Spain, Italy, France, and more are facing new outbreaks of the virus. Furthermore, several other countries are facing a significant growth in the number of daily infections: Argentina, Japan, Ukraine, India, Peru, Mexico, Colombia, and more.